Travere Therapeutics
TVTX
#3235
Rank
A$6.94 B
Marketcap
A$72.40
Share price
-3.86%
Change (1 day)
30.91%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): A-$1.86

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.93. In 2025 the company made an earnings per share (EPS) of A-$0.43 an increase over its 2024 EPS that were of A-$6.15.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.86327.94%
2025A-$0.43-92.93%
2024A-$6.15154.66%
2023A-$2.41-63.16%
2022A-$6.5544.22%
2021A-$4.54-10.09%
2020A-$5.05
2018A-$3.8164.94%
2017A-$2.31
2015A$5.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.28-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.42-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA